Seven Grand Managers’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLN
SL
Seven Grand Managers's SLN Position: Q3 2026 in Review
Seven Grand Managers opened a new position in Silence Therapeutics (SLN) in Q3 2026: 250,000 shares worth $2.73M. The stake represents 0.1% of the portfolio and ranks #97 among its holdings.
92 funds tracked by Wall St. Rank hold SLN as of Q3 2026.
- Seven Grand Managers held 250,000 shares of Silence Therapeutics worth $2.73M as of Q3 2026.
- Silence Therapeutics was a new Seven Grand Managers position in Q3 2026.
- Silence Therapeutics made up 0.1% of Seven Grand Managers's portfolio in Q3 2026, its #97 holding.
- 92 funds tracked by Wall St. Rank held Silence Therapeutics as of Q3 2026.
Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.